摘要
研究收集了1995—2014年国家自然科学基金委(Natural Science Foundation of China,NSFC)资助的中药学领域项目中分子生药相关研究共595项,采用TDA等工具对NSFC资助项目概况、热点研究内容进行分类排序,并进行热点研究内容相关性分析。国家自然科学基金资助生药学研究中,分子生药技术相关项目及经费数量逐渐增加,经费占中药学研究经费的比重趋于稳定;主要支持了用分子生物学的研究方法对道地药材、次生代谢以及种质资源的研究;热点药物包括丹参、地黄、冬虫夏草等,热点内容包括丹参酮的生物合成、地黄的连作障碍等。
This study collected 1995-2014 molecular pharmacognosy study,a total of 595 items,funded by Natural Science Foundation of China（ NSFC）. TDA and Excel software were used to analyze the data of the projects about general situation,hot spots of research with rank analytic and correlation analytic methods. Supported by NSFC molecular pharmacognosy projects and funding a gradual increase in the number of,the proportion of funds for pharmaceutical research funding tends to be stable; mainly supported by molecular biology methods of genuine medicinal materials,secondary metabolism and Germplasm Resources Research; hot drugs including Radix Salviae Miltiorrhizae,Radix Rehmanniae,Cordyceps sinensis,hot contents including tanshinone biosynthesis,Rehmannia glutinosa continuous cropping obstacle.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2016年第9期1617-1621,共5页
China Journal of Chinese Materia Medica
基金
中国中医科学院科技创新团队项目(PY1306)
